Cargando…

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles

INTRODUCTION: The resistance profiles of first-line antiretroviral therapy (ART) regimens after virologic failure have yet to be studied in a clinic setting in the modern treatment era. Time to virologic failure among three standard first-line regimens and the resistance profiles of these failures w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crouzat, Frederic, Benoit, Anita, Kovacs, Colin, Smith, Graham, Taback, Nathan, Sandler, Ina, Brunetta, Jason, Chang, Benny, Merkley, Barry, Tilley, David, Fletcher, David, Kalaria, Dipen, Loutfy, Mona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P225
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225355/ https://www.ncbi.nlm.nih.gov/pubmed/25397502 http://dx.doi.org/10.7448/IAS.17.4.19757

Ejemplares similares

HISTOPLASMOSE DISSEMINADA: MANIFESTAÇÃO CLÍNICA INICIAL DE PACIENTE AIDS COM COINFECÇÃO PELO SARS‐COV2
por: Barroso, Harianne Gedeon B., et al.
Publicado: (2021)

Can urban gardens improve food security, health, well-being and financial sustainability of households?
por: Guerreiro, Helena, et al.
Publicado: (2021)

RÁPIDA INSERÇÃO E DISSEMINAÇÃO DA RESISTÊNCIA BACTERIANA EM UMA UNIDADE COVID E O IMPACTO NO TRATAMENTO ANTIMICROBIANO EMPÍRICO DE PACIENTES COM BACTEREMIA
por: Chagas, Alan Pereira, et al.
Publicado: (2022)

Patients’ willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands
por: Engelhard, Esther, et al.
Publicado: (2014)

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
por: Saracino, Annalisa, et al.
Publicado: (2014)

The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART
por: Kiselinova, Maja, et al.
Publicado: (2014)

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: 96 weeks post VERITAS study
por: Trottier, Benoit, et al.
Publicado: (2014)

Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy
por: Erdbeer, Gesa, et al.
Publicado: (2014)

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

Evolution of resistance in paediatric patients with failure on antiretroviral therapy
por: Orrell, C, et al.
Publicado: (2012)

725 Evaluating Wound Care Compliance, Healing and Perceptions in Burn Patients Discharged to Post-Acute Care Facilities
por: Osborn, Suzanne, et al.
Publicado: (2023)

726 Enteral Tube Clogging and Medication Administration Techniques
por: Rathjen, Esther, et al.
Publicado: (2023)

728 A Survey of Health Professionals' Attitudes Regarding Substance Abuse Disorder in Burn Patients
por: Richey, Karen, et al.
Publicado: (2023)

729 A Post-Pandemic Educational Program for New Burn Nurses
por: Klinkhamer, Angela, et al.
Publicado: (2023)

727 Development of an Acuity and Scheduling System for Wound Care
por: Salazar, Elizabeth, et al.
Publicado: (2023)

730 Geographic Effects of Rural Burn Care Follow Up During the COVID-19 Pandemic
por: Bradshaw, Evan, et al.
Publicado: (2023)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis
por: Stellbrink, Hans-Juergen, et al.
Publicado: (2014)

Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
por: Marije Hofstra, Laura, et al.
Publicado: (2014)

Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
por: Gutierrez-Liarte, Angela, et al.
Publicado: (2014)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Clinical and socio-demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART-1
por: Daniel Labhardt, Niklaus, et al.
Publicado: (2014)

A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expect
por: Silva, Joana, et al.
Publicado: (2014)

Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study
por: Leierer, Gisela, et al.
Publicado: (2014)

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
por: Fisher, Martin, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials
por: Reeves, Iain, et al.
Publicado: (2014)

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics
por: Ammassari, Adriana, et al.
Publicado: (2014)

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study
por: Burch, Lisa, et al.
Publicado: (2014)

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression
por: Llibre, Josep M, et al.
Publicado: (2014)

Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
por: Philippe Küpper-Tetzel, Claus, et al.
Publicado: (2014)

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
por: Montes, Marisa, et al.
Publicado: (2014)

Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis
por: Arribas, Jose, et al.
Publicado: (2014)

Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI
por: Maria Bottani, Giulia, et al.
Publicado: (2014)

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
por: Luis Casado, Jose, et al.
Publicado: (2014)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Real-world medication persistence with single versus multiple tablet regimens for HIV-1 treatment
por: Sweet, Donna, et al.
Publicado: (2014)

Nephrolithiasis and renal failure among patients exposed to atazanavir, other PIs and PI-free regimens
por: Nkhoma, Ella, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6fbhuga87h8gknj596jceh4krt